Xingjuan Chang

Title: **The Innovative Contributions of Inventor Xingjuan Chang**

Introduction

Xingjuan Chang, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of pharmaceuticals. With a focus on innovative treatments, he holds one patent that showcases his commitment to advancing medical science and improving patient outcomes.

Latest Patents

The standout patent attributed to Xingjuan Chang is titled "Naphthyridinone derivatives for the treatment of a disease or disorder." This invention relates to a compound represented by a specific formula, as well as its pharmaceutically acceptable salts. The patent also discusses various compositions and methods for using these compounds, indicating a profound dedication to addressing various diseases or disorders through innovative chemical solutions.

Career Highlights

Xingjuan Chang is currently employed at Novartis AG, a leader in the global pharmaceutical industry that is known for its dedication to research and development. His work is characterized by a deep understanding of medicinal chemistry, where he has contributed to developing compounds that hold the potential to revolutionize treatment methodologies.

Collaborations

Throughout his career, Xingjuan Chang has worked alongside esteemed colleagues, including Atwood Kim Cheung and Donglei Liu. These collaborations highlight not only his capacity for teamwork but also his ability to contribute to collective efforts to drive innovation in pharmaceuticals.

Conclusion

As an inventor, Xingjuan Chang exemplifies the spirit of innovation within the pharmaceutical industry. His patent on naphthyridinone derivatives underlines his commitment to developing effective treatments, showcasing his vital role at Novartis AG and in the broader medical community. Through his collaborations and ongoing work, Chang continues to impact the field of medicine significantly.